Summary
Transport by ATP-dependent efflux pumps such as P glycoprotein (Pgp) and multidrug resistance associated protein (MRP), encoded by multidrug resistant (MDR) associated genes, is an increasingly recognized mechanism by which cells maintain substrate homeostasis and evade drug therapy. Pgp and MRP are members of the so-called ATP binding cassette (ABC) transporters superfamily, which are associated with many biological processes in both prokaryotes and eukaryotes, as well as clinical problems. The observation of upregulated sequences that are homologous to the Mycobacterium smegmatis phage resistance (mpr) gene and putative ABC transporters subunits in fetal Down syndrome (DS) using the gene hunting technique, subtractive hybridization formed the Rationale for this study. The expression of Pgp and MRP1 is therefore investigated in different brain regions of controls and adult DS patients with western blot technique. No apparent changes were observed between controls and DS in levels of Pgp in all brain regions examined. By contrast, MRP1 detection using the rat monoclonal antibody (MRPrl) produced a significant elevation in DS temporal cortex (P < 0.01) and parietal cortex (P < 0.05). Although MRP1 detected with the mouse monoclonal antibody (MRPm6) tended to increase in most of the regions of DS brain, it failed to reach significance level. Age or postmortem interval did not correlate with protein levels in both controls as well as DS. Taken together, the current data provide evidence for the presence of MDR related pumps in different regions of the human brain. In addition, overexpression of MRP1 in DS brain may have some relevance to the disorder either by deranging substrate homeostasis or limiting drug access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Busciglio J, Yankner BA (1995) Apoptosis and increased generation of active oxygen species in Down syndrome neurons in vitro. Nature 378: 776–779
Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EV, Duncan AMV, Deeley RG (1992) Overexpression of a transporter gene in a multidrug resistance human lung cancer cell line. Science 258: 1650–1654
Decleves X, Regina A, Laplanche JL, Roux F, Boval B, Launay JM, Scherrmann JM (2000) Functional expression of P-glycoprotein and multidrug resistance associated protein (MRP1) in primary cultures of astrocytes. J Neurosci Res 60: 594–601
Epstein CJ (2001) Down syndrome (Trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 1223–1256
Flens MJ, Izquierdo MA, Scheffer GL, Fritz JM, Meijer CJLM, Scheper RJ, Zaman GJR (1994) Immunohistochemical detection of the multidrug resistance associated protein MRP in human multidrug resistant tumor cell by monoclonal antibodies. Cancer Res 54: 4557–4563
Fromm MF (2000) P-glycoprotein: a defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 38: 69–74
Ghersi-Egea JF, Strazielle N (2001) Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 52: 83–88
Gottesman MM, Pastan I (1993) Biochemistry of multidrug resistance mediated by the multidrug resistance transporter. Annu Rev Biochem 62: 385–427
Grandjean F, Bremaud L, Verdier M, Robert J, Ratinaud M-H (2001) Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicinresistant human K562 cell lines. Anti-Cancer Drugs 12: 247–258
Greber-Platzer S, Lubec G, Langen H, Fountoulakis M (1999) Decreased levels of synaptosomal associated protein 25 in the brain of patients with Down syndrome and Alzheimer’s disease. Electrophoresis 20: 928–934
Higgins CF (1992) ABC transporters: From microorganisms to man. Annu Rev Cell Biol 8: 67–113
Huai-Yun H, Secrest DT, Mark KS, Carney D, Brandquist C, Elmquist WF, Miller DW (1998) Expression of Multidrug-Resistance associated protein (MRP) in brain microvessel endothelial cells. Biochem Biophys Res Commun 243: 816–820
Iannello RC, Crack PJ, de Haan JW, Kola I (1999) Oxidative stress and neural dysfunction in Down syndrome. J Neural Transm 57: 257–267
Ischikawa I (1992) The ATP dependent glutathione-S export pump. Trends Biochem Sci 17:463–468
Jirsch J, Deeley RG, Cole SPC, Stewart AJ, Fedida D (1993) Inwardly rectifying potassium channels and volume regulated anion channels in multidrug resistant small cell lung cancer. Cancer Res 53: 4156–4160
Kool M, de Haas M, Scheffer GL, Scheper RJ, van Eijk MJT, Juijin JA, Baas F, Borst P (1997) Analysis of expression CMOAT (MRP2), MRP3, MRP4, and MRP5, homoogues of MRP1 in human cancer cell lines. Cancer Res 57: 3537–3547
Kool M, van der Linden M, de Haas F, Borst P (1999) Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. Cancer Res 59: 175–182
Krishnamachary N, Center MS (1993) The MRP gene associated with a non-P glycoprotein multidrug resistance encodes a 190 kDa membrane bound glycoprotein. Cancer Res 53: 3658–3661
Ling V (1997) Multidrug resistance: molecular mechanisms and clinical relevance. Cancer Chemother Pharmacol 40: S3–8
Loe DW, Deeley RG, Cole SPC (1996) Biology of the multidrug resistance associated protein, MRP. Eur J Cancer 32A: 945–957
Loe DW, Deeley RG, Cole SPC (1998) Characterization of vincristine transport by the Mr 190000 multidrug resistant protein (MRP): evidence for co-transport with reduced glutathione. Cancer Res 58: 5130–5136
Mohri M, Nitta H, Yamashita J (2001) Expression of multidrug resistance associated protein in human gliomas. J Neurooncol 49: 105–115
Payen L, Courtois A, Loewert M, Guillouzo A, Fardel O (2001) Reactive oxygen species related induction of multidrug resistance associated protein2 expression in primary hepatocytes exposed to sulforaphane. Biochem Biophys Res Commun 282: 257–263
Rao V, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, Piwnica- Worms D (1999) Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance associated protein contribute to the blood cerebrospinal fluid drug permeability barrier. Proc Natl Acad Sci USA 96: 3900–3905
Rappa G, Lorico A, Flavell RA, Sartorelli AC (1997) Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57: 5232–5237
Regina A, Koman A, Piciotti M, El Hafny B, Center MS, Bergmann R, Couraud PO, Roux F (1998) Mrpl multidrug resistance associated protein and P-glycoprotein expression in rat brain microvessel endothelial cells. J Neurochem 71: 705–715
Renes J, de Vries EEG, Hooiveld GJEJ, Krikken I, Jansen PLM, Müller M (2000) The multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem J 350: 555–561
Scheper RJ, Bulte JW, Brakkee JGP, Quak JJ, van Der Schoot E, Balm AJM, Meijer CJLM, Broxterman HJ, Kuiper CM, Lankelma J, Pinedo HM (1988) Monoclonal antibody JSB-1 detects a highly conserved epitope on the P-glycosylation associated with multidrug resistance. Int J Cancer 42: 389–394
Seetharaman S, Barrand MA, Maskell L, Scheper RJ (1998) Multidrug resistance related transport proteins in isolated human brain microvessels and in cells cultured from these isolates. Neurochem 70: 1151–1119
Wang F, Dong Z, Luo J (1998) The clinical significance of multidrug resistance associated (MRP) gene exression in acute leukemia. Zhonghua Xve Ye Xue Za Zhi 19: 63–66
Yamane Y, Furuichi, Song R, Van NT, Mulcahy RT, Ishikawa T, Kuo MT (1998) Expression of multidrug resistance protein/GS-X pump and y-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem 273: 31075–31085
Zaman GJR, Versantvoort CHM, Smith JJM, Eijdems EWHM, de Haas M, Smith AJ, Broxterman HJ, Mulder NH, de Vries EGE, Baas F, Borst P (1993) Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multi drug resistant lung cancer cell lines. Cancer Res 53: 1747–1750
Zhang Y, Han H, Elmquist WF, Miller DW (2000) Expression of various multidrug resistance associated protein (MRP) homologues in brain microvessel endothelial cells. Brain Res 876: 148–153
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag/Wien
About this chapter
Cite this chapter
Engidawork, E., Roberts, J.C., Hardmeier, R., Scheper, R.J., Lubec, G. (2001). Expression of the multidrug resistance P glycoprotein (Pgp) and multidrug resistance associated protein (MRP1) in Down syndrome brains. In: Lubec, G. (eds) Protein Expression in Down Syndrome Brain. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6262-0_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6262-0_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83704-7
Online ISBN: 978-3-7091-6262-0
eBook Packages: Springer Book Archive